Background: Zimbabwe experienced an increasein HIV incidence and mortality rates between 2009 and 2011 despite improved HIV/AIDS financing. The aim of this study was to investigate the associations between HIV/AIDS financing and HIV incidence and mortalities from 2009 to 2013 in Zimbabwe.
Methods: A secondary data analysis of existing data on HIV/AIDS financing trends and HIV incidence and mortality rates in Zimbabwe from 2009 to 2013 was carried out. Pearson’s product moment correlation coefficient analysis and t-test were carried out using STATA®version 12 to generate evidence.
Results: There was moderate positive correlation (r = +0.63) between HIV/AIDS financing and HIV incidence rate which was not statistically significant (p>0.05). The correlation between HIV/AIDS financing and HIV-related mortality rate in Zimbabwe (2009-2013) was poor (r=+0.15) (p>0.05). Total HIV/AIDS financing increased by 323 %in Zimbabwe from 2009-2013.
Conclusions: This study showed that improving HIV/AIDS financing could notdirectly influence HIV incidence and mortality rates in Zimbabwe. Other factors such as health system and patient factors may be primary determinants of HIV incidence and mortality rates in developing countries.
Impact Factor
2022: 6.012
This work is licensed under a